Abstract
Context/Objective
To evaluate the impact of long-term nitrofurantoin for UTI prophylaxis in veterans with SCI.
Design
Matched pairs study.
Setting
Veterans cared for at VA facilities from 10/1/2012-9/30/2013.
Participants
Veterans.
Interventions
n/a.
Outcomes measures
UTI, positive urine cultures, resistant cultures.
Methods
Cases receiving long-term nitrofurantoin (≥90 days supply) were matched to controls by facility. Controls were patients who did not receive long-term nitrofurantoin with a history of ≥3 positive urine cultures and at least one diagnosis of UTI or asymptomatic bacteriuria in the previous year.
Results
122 SCI cases were identified and matched to 196 controls. After adjusting for differences in baseline demographic characteristics, UTIs were less frequent in cases (OR = 0.60 [95% CI 0.44-0.72]). Cases had a greater mean number of days between positive urine cultures as compared to controls (<0.0001). Cases were more likely to have isolates resistant to nitrofurantoin (P ≤ 0.0001); however, the frequency of multi-drug resistant organisms isolated from the urine was not significantly different.
Conclusions
Long-term prescription of nitrofurantoin may reduce UTIs in veterans with SCI and there is no evidence that it promotes multi-drug resistance. Future prospective studies should be conducted prior to incorporating routine use of long-term nitrofurantoin into clinical care.
Acknowledgements
The authors wish to thank Dr. Beverly Gonzalez for statistical expertise and manuscript review. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs of the United States government.
Disclaimer statements
Contributors None.
Conflicts of interest The authors have no conflicts of interest to declare.
Ethics approval None.